Presidential Panel Says High-Priced Cancer Drugs Harm Patient Care

TUESDAY, March 13, 2018 — “Financial toxicity” caused by high cancer drug prices is harming people’s ability to fight the dreaded disease, a new report from the President’s Cancer Panel warns.
The report, released Tuesday, argues that urgent action…
Source: Topamax